about
Laparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure?Statins for primary cardiovascular prevention in the elderlySeverity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.Efficacy of treatment for hyperglycemic crisis in elderly diabetic patients in a day hospital.Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen.Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational studyCerebral salt wasting syndrome: review.Synovial fluid adipokines are associated with clinical severity in knee osteoarthritis: a cross-sectional study in female patients with joint effusion.Carcinoid tumor of the thymus associated with Cushing's syndrome and dysgeusia: case report and review of the literature.Infradiagnosed complications of chronic diabetes mellitus: the value of systematic review in a single visit.Type 1 diabetes, metabolic syndrome and cardiovascular risk.Obesity and type 1 diabetes mellitus management.Bariatric surgery: to whom and when?Role of First-Trimester HbA1c as a Predictor of Adverse Obstetric Outcomes in a Multiethnic Cohort.Predictors of Hypertension Remission and Recurrence After Bariatric Surgery.[Cardiovascular prevention in diabetes mellitus: A multifactorial challenge].[Testosterone deficiency, metabolic syndrome and diabetes mellitus].Testosterone undecanoate improves lipid profile in patients with type 1 diabetes and hypogonadotrophic hypogonadism.[Panhypopituitarism and cranial nerve IV palsy: pituitary macroadenoma?].Peripartum metabolic control in gestational diabetes.Severe rhabdomyolysis and hyponatremia induced by picosulfate and bisacodyl during the preparation of colonoscopy.Role of A1c in the postpartum screening of women with gestational diabetes.Gestational diabetes in a multiethnic population of Spain: clinical characteristics and perinatal outcomes.Panhypopituitarism in a pregnant women caused by a cystic sellar lesion.[Atherogenic dyslipidemia in patients with type 1 diabetes mellitus].[Metabolic syndrome, type 1 diabetes mellitus and insulin resistance].Is first-trimester HbA1c useful in the diagnosis of gestational diabetes?Clinical Value of Thyrotropin Receptor Antibodies for the Differential Diagnosis of Interferon Induced Thyroiditis.Impact of different criteria on type 2 diabetes remission rate after bariatric surgery.Impact of hyponatremia on mortality and morbidity in patients with COPD exacerbations.[Dapagliflozin: Beyond glycemic control in the treatment of type 2 diabetes mellitus].Estimated Glucose Disposal Rate in Assessment of the Metabolic Syndrome and Microvascular Complications in Patients with Type 1 Diabetes.Impact of overt diabetes diagnosed in pregnancy in a multi-ethnic cohort in SpainGestational diabetes mellitus in a multiethnic population in Spain: Incidence of and factors associated to impaired glucose tolerance one year after deliveryHypopituitarism associated with mycotic aneurysm of the cavernous carotid artery in a renal transplant recipientA prospective evaluation of neonatal hypoglycaemia in infants of women with gestational diabetes mellitusInsulin resistance and hypertension in patients with type 1 diabetes[Panhypopituitarism due to giant pituitary adenoma][Chronic complications in type 1 diabetes mellitus. Analysis of a cohort of 291 patients with a mean evolution time of 15 years]High prevalence of cardiovascular co-morbidities in patients with symptomatic knee or hand osteoarthritis
P50
Q26778002-C5632BC2-6881-485E-83BA-1794A823EA93Q26783401-75F73A52-B984-457B-8A95-CC3DA6ACD9E7Q31131725-82E98817-D6A6-408D-8C84-94EEF203FB2CQ33636971-F37B2ED3-88BC-4AF0-AB67-074B70C988C2Q34179368-8757B27F-A952-4271-96F6-5189CB6B41D1Q35073928-CB5B6F34-670F-4B0F-8ACC-0B5310A3CF30Q37159814-7BED5E2D-F493-49C8-B3D0-AB2EE22D2C8AQ37258136-175FA0F0-6939-4C22-9453-DAA5EF0420BEQ37622127-85090D6E-13E0-4F0D-BE71-6937B1F57F2EQ38057094-116E8399-25B7-46BE-8869-56D7F260D920Q38166074-0126211C-5AF8-477E-B08D-B9C1E592CE99Q38270105-33E6784D-B8DC-40DD-BB71-6AD64A287B23Q38349391-30D3079E-19D5-43FE-921C-C4301A67A3A5Q39158736-E16216B5-4A97-434B-8DD4-000D5C6B61CEQ40561823-4B74FACA-6D77-4A48-B59C-ABB9A44A6AD4Q41060990-3295EBE2-A4C8-48BC-A6C7-956822555EDEQ41267471-4D62D65F-8168-4B1D-A6C6-8A3ABCF923EAQ42496727-6C18D2D1-7440-40E6-95A2-CC6D6E0C2201Q42852665-F01B1718-FD33-4170-9702-70CF17D5EA6EQ43129009-78BBD563-FBDB-46A7-B101-8A9C74943ED8Q43523934-3DECF176-04C3-493B-B4E8-7CCC7A18D70BQ44682380-A8B9FC14-C4DA-4754-B7E7-972412DBDE3CQ44761878-E7BD178A-21F1-4319-BDBF-A8FD457B02C8Q45175051-D843D594-0826-4B4B-933A-262D029ED57DQ46482161-36874301-8A9C-42B2-9848-D3A4A27EC191Q46649944-7E0A3483-06BE-4413-A576-8C91062E9D7BQ47684580-C5CD1C03-912A-4A5C-BC0C-B839CDC93283Q50276074-AB5BD81C-D5BB-4B50-B9E7-09E364A7258DQ51322343-98E18580-483D-4F25-A723-DFB99492FC83Q51476009-4BF4AD3B-8D0F-4F4C-825E-1DADBE4240E8Q54523463-F4CEF532-61E0-4DA4-972E-94976991F380Q54912237-55E5A5CE-5624-4DE0-98CA-3D273BE8F026Q57453282-BFB8B450-88F2-4513-9CD1-51AA501359E0Q57481550-01621EEE-6273-48BE-9D4A-9A4715D9F9B5Q80142957-C03612DD-4795-475F-B5C4-1BB365AC9F7FQ84003454-0BA0F418-98A5-4E65-A6AA-527F346F0C60Q84161563-557B0973-841A-4157-903A-A06E8BC92C13Q84187755-AB32E13D-52A2-43A6-A94A-A0FE2DD7DFA3Q84527746-B9F48875-582C-42CC-9811-CE56E43E5547Q86014743-D99ED595-9FB9-4E3C-9619-DC8F509FB69B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Juan José Chillarón
@en
Juan José Chillarón
@nl
type
label
Juan José Chillarón
@en
Juan José Chillarón
@nl
prefLabel
Juan José Chillarón
@en
Juan José Chillarón
@nl
P31
P496
0000-0002-8096-1703